We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Handle with care

5 September 2017 By Alec Macfarlane

The group is set to sell nearly $13 bln of shares, in a follow-on to 2015’s blockbuster IPO. The stock looks cheap and pays a big dividend. But growth is mediocre and the shares have underperformed since the original listing. Investors should be able to push hard on price.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)